Literature DB >> 20573802

NF-κB as a central regulator of macrophage function in tumors.

Subhra K Biswas1, Claire E Lewis.   

Abstract

TAMs are usually abundant in the tumor microenvironment and are now known to play an essential role in tumor progression. For example, TAMs influence many aspects of tumorigenesis, such as the growth, survival, invasion, and metastasis of tumor cells, tumor angiogenesis, and the suppression of other tumor-infiltrating immune effector cells. The molecular pathways that regulate these tumor-promoting functions of TAMs are currently under intense investigation. Several recent studies about transgenic murine tumor models have shown that the transcription factor NF-κB is a key player in tumor progression with distinct roles in regulating the functions of macrophages and tumor cells in malignant tumors. Here, we outline the evidence for classical and noncanonical NF-κB signaling pathways driving the tumor-promoting repertoire of TAMs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573802     DOI: 10.1189/jlb.0310153

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  51 in total

1.  Epithelial cells modulate genes associated with NF kappa B activation in co-cultured human macrophages.

Authors:  I Striz; E Brabcova; L Kolesar; X D Liu; I Brabcova; A Sekerkova; J A Poole; M Jaresova; A Slavcev; S I Rennard
Journal:  Immunobiology       Date:  2011-05-01       Impact factor: 3.144

2.  Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs.

Authors:  Makon-Sébastien Njock; Henry S Cheng; Lan T Dang; Maliheh Nazari-Jahantigh; Andrew C Lau; Emilie Boudreau; Mark Roufaiel; Myron I Cybulsky; Andreas Schober; Jason E Fish
Journal:  Blood       Date:  2015-04-02       Impact factor: 22.113

Review 3.  The role of ADAM17 in tumorigenesis and progression of breast cancer.

Authors:  Hongyu Shen; Liangpeng Li; Siying Zhou; Dandan Yu; Sujin Yang; Xiu Chen; Dandan Wang; Shanliang Zhong; Jianhua Zhao; Jinhai Tang
Journal:  Tumour Biol       Date:  2016-09-22

4.  IL-37 mediates the antitumor activity in renal cell carcinoma.

Authors:  Yazhuo Jiang; Yili Wang; Liang Liang; Yang Gao; Juan Chen; Yi Sun; Yongyi Cheng; Yonggang Xu
Journal:  Med Oncol       Date:  2015-10-13       Impact factor: 3.064

5.  Identification and verification of PRDX1 as an inflammation marker for colorectal cancer progression.

Authors:  Guanghui Chu; Juntang Li; Yali Zhao; Ningning Liu; Xiaoshan Zhu; Qinqin Liu; Dong Wei; Chunfang Gao
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

6.  The Critical Role of Proteolytic Relay through Cathepsins B and E in the Phenotypic Change of Microglia/Macrophage.

Authors:  Junjun Ni; Zhou Wu; Christoph Peterts; Kenji Yamamoto; Hong Qing; Hiroshi Nakanishi
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

Review 7.  Contribution of Adipose Tissue to Development of Cancer.

Authors:  Alyssa J Cozzo; Ashley M Fuller; Liza Makowski
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

Review 8.  Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment.

Authors:  P Allavena; A Mantovani
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

9.  Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery.

Authors:  Adrienn Volak; Stanley G LeRoy; Jeya Shree Natasan; David J Park; Pike See Cheah; Andreas Maus; Zachary Fitzpatrick; Eloise Hudry; Kelsey Pinkham; Sheetal Gandhi; Bradley T Hyman; Dakai Mu; Dwijit GuhaSarkar; Anat O Stemmer-Rachamimov; Miguel Sena-Esteves; Christian E Badr; Casey A Maguire
Journal:  J Neurooncol       Date:  2018-05-16       Impact factor: 4.130

Review 10.  Anti-tumour strategies aiming to target tumour-associated macrophages.

Authors:  Xiaoqiang Tang; Chunfen Mo; Yongsheng Wang; Dandan Wei; Hengyi Xiao
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.